← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2007Last known activity
Dec 4, 2025
Timeline
1990s
- Jan 1, 1992
Medpace, Inc.— Founded
Drugs by trial phase (106 distinct, 108 trials)
Phase 3 (23 own, 0 via acquisition)
Phase 2 (42 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Lung Injury
- Alzheimer Disease
- Amyloidosis
- Anemia, Iron-Deficiency
- Anemia, Sickle Cell
- Bacterial Infections
- Breast Neoplasms
- Bursitis
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Cerebral Infarction
- Clostridium Infections
- Cognitive Dysfunction
- Communicable Diseases
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Digestive System Neoplasms
- Dyslipidemias
- Embolism
- Gastrointestinal Neoplasms
- Glomerulosclerosis, Focal Segmental
- Gout
- Head and Neck Neoplasms
- Heart Failure
- Hepatitis B
- Herpes Genitalis
- Herpes Simplex
- Hypercholesterolemia
- Hyperkalemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Hypertriglyceridemia
- Infections
- Ischemia
- Kidney Diseases
- Liver Diseases
- Lymphoma, Non-Hodgkin
- Neoplasms
- Neoplasms, Connective and Soft Tissue
- Obesity
- Osteoarthritis
- Pancreatic Neoplasms
- Polycystic Ovary Syndrome
- Pulmonary Embolism
- Pyelonephritis
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Tract Neoplasms
- Schizophrenia
- Severe Acute Respiratory Syndrome
- Skin Neoplasms
- Soft Tissue Neoplasms
- Stroke
- Syndrome
- Tachycardia
- Tachycardia, Supraventricular
- Thrombocythemia, Essential
- Thrombocytosis
- Thromboembolism
- Thrombosis
- Urinary Tract Infections
- Urogenital Neoplasms
- Venous Thromboembolism
- Venous Thrombosis
Recent trials (50)
- NCT07310901OfficialPhase 1Dec 4, 2025
- NCT07189871CollaboratorPhase 1/Phase 2Nov 30, 2025
- NCT07171619OfficialPhase 1Sep 9, 2025
- NCT06777433CollaboratorPhase 2Dec 13, 2024
- NCT06516510CollaboratorEarly Phase 1Oct 31, 2024
- NCT06504043CollaboratorPhase 1Aug 31, 2024
- NCT05670379CollaboratorPhase 1Mar 31, 2024
- NCT05983250CollaboratorPhase 3Nov 30, 2023
- NCT06133478OfficialPhase 1Nov 27, 2023
- NCT06133478Overall official - principal investigatorPhase 1Nov 27, 2023
- NCT06133478CollaboratorPhase 1Nov 27, 2023
- NCT06066580CollaboratorPhase 2Nov 2, 2023
- NCT05986851CollaboratorPhase 2Sep 12, 2023
- NCT05757492CollaboratorPhase 1/Phase 2Apr 26, 2023
- NCT05572190OfficialPhase 1Sep 27, 2022
Details
- Founded
- Cincinnati, OH, US Jan 1, 1992
- Last known activity
- Dec 4, 2025
Notes
--- Pre-folding founded info: 1992-06-01 Cincinnati OH US https://en.wikipedia.org/wiki/Medpace ---